Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01647438 · ClinicalTrials.gov registry record · NA
Translating a Heart Disease Lifestyle Intervention Into the Community
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT01647438: Completed NA study, sponsored by Northwestern University.
NCT01647438 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01647438, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
Translating a Heart Disease Lifestyle Intervention in the Community study will evaluate the feasibility and initial effectiveness of a community-based, culturally-targeted, lifestyle intervention to improve the cardiovascular health of underserved South Asian (Indian, Pakistani, Bangladeshi, Nepali, and Sri Lankan) Americans. Participants in this study will be randomly assigned to either a group to receive heart disease prevention classes or to another group where they will receive written materials about heart disease prevention.
Primary Outcome
Change from baseline in minutes per week of physical activity measured by accelerometer at 6-months.
Interventions
- BEHAVIORAL Lifestyle Intervention
- OTHER Print Health Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-02 |
| Phase | NA |
What the finished NCT01647438 record still lists
NCT01647438 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Lifestyle Intervention is the first listed.
NCT01647438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01647438 about?
NCT01647438 is a clinical study titled "Translating a Heart Disease Lifestyle Intervention Into the Community". Translating a Heart Disease Lifestyle Intervention in the Community study will evaluate the feasibility and initial effectiveness of a community-based, culturally-targeted, lifestyle intervention to improve the cardiovascular health of underserved South Asian (Indian, Pakistani, Bangladeshi, Nepali,...
What is the current status of trial NCT01647438?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2012-08. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01647438?
The interventions under investigation include: Lifestyle Intervention (BEHAVIORAL), Print Health Education (OTHER).
Who is sponsoring clinical trial NCT01647438?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01647438's enrollment target sits among peer trials
63 1157th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia